(Q36372815)

English

Optimizing the HRP-2 in vitro malaria drug susceptibility assay using a reference clone to improve comparisons of Plasmodium falciparum field isolates

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Optimizing the HRP-2 in vitro malaria drug susceptibility assay using a reference clone to improve comparisons of Plasmodium falciparum field isolates (English)

1 reference

Europe PubMed Central

13 August 2017

Plasmodium falciparum

0 references

0 references

10

object named as

Chanthap Lon

1 reference

Europe PubMed Central

13 August 2017

Paktiya Teja-Isavadharm

4

object named as

Paktiya Teja-Isavadharm

1 reference

Europe PubMed Central

13 August 2017

author name string

Wiriya Rutvisuttinunt

1

1 reference

Europe PubMed Central

13 August 2017

Suwanna Chaorattanakawee

2

1 reference

Europe PubMed Central

13 August 2017

Stuart D Tyner

3

1 reference

Europe PubMed Central

13 August 2017

Youry Se

5

1 reference

Europe PubMed Central

13 August 2017

Kritsanai Yingyuen

6

1 reference

Europe PubMed Central

13 August 2017

Panjaporn Chaichana

7

1 reference

Europe PubMed Central

13 August 2017

Delia Bethell

8

1 reference

Europe PubMed Central

13 August 2017

Douglas S Walsh

9

1 reference

Europe PubMed Central

13 August 2017

Mark Fukuda

11

1 reference

Europe PubMed Central

13 August 2017

Duong Socheat

12

1 reference

Europe PubMed Central

13 August 2017

Harald Noedl

13

1 reference

Europe PubMed Central

13 August 2017

Kurt Schaecher

14

1 reference

Europe PubMed Central

13 August 2017

David L Saunders

15

1 reference

Europe PubMed Central

13 August 2017

publication date

13 September 2012

1 reference

Europe PubMed Central

13 August 2017

Malaria Journal

1 reference

Europe PubMed Central

13 August 2017

11

1 reference

Europe PubMed Central

13 August 2017

325

1 reference

Europe PubMed Central

13 August 2017

https://scigraph.springernature.com/pub.10.1186/1475-2875-11-325

0 references

Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

Reliability of antimalarial sensitivity tests depends on drug mechanisms of action.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

The SYBR Green I malaria drug sensitivity assay: performance in low parasitemia samples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

Artemisinin Resistance in Plasmodium falciparum Malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

Evidence of Artemisinin-Resistant Malaria in Western Cambodia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

Detection of Plasmodium falciparum Histidine-rich Protein II in Saliva of Malaria Patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

False-positive results of a Plasmodium falciparum histidine-rich protein 2-detecting malaria rapid diagnostic test due to high sensitivity in a community with fluctuating low parasite density.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

Malaria drug-sensitivity testing: new assays, new perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

Histidine-rich protein II: a novel approach to malaria drug sensitivity testing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

Detection of histidine rich protein 2 and panmalarial ICT Malaria Pf/Pv test antigens after chloroquine treatment of uncomplicated falciparum malaria does not reliably predict treatment outcome in eastern Indonesia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

Human malaria parasites in continuous culture

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

Synchronization of Plasmodium falciparum Erythrocytic Stages in Culture

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

World Antimalarial Resistance Network (WARN) II: in vitro antimalarial drug susceptibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

30 September 2017

Antimalarial drug sensitivity profile of western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay and molecular analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

28 June 2018

Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

28 June 2018

Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

28 June 2018

A histidine-rich protein 2-based malaria drug sensitivity assay for field use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

28 June 2018

Drug-resistant malaria in Bangladesh: an in vitro assessment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

28 June 2018

3H-hypoxanthine incorporation into fresh and stored blood: implications for resistance determination in P. falciparum malaria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489509

28 June 2018

Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay

1 reference

https://api.crossref.org/works/10.1186%2F1475-2875-11-325

21 January 2018

A simplified liquid chromatography-mass spectrometry assay for artesunate and dihydroartemisinin, its metabolite, in human plasma

1 reference

https://api.crossref.org/works/10.1186%2F1475-2875-11-325

21 January 2018

Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression.

1 reference

https://api.crossref.org/works/10.1186%2F1475-2875-11-325

21 January 2018

Identifiers

10.1186/1475-2875-11-325

1 reference

Europe PubMed Central

13 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36372815&oldid=1764016736"